(KBH) KB Home - Ratings and Ratios
Homes, Townhomes, Condominiums, Mortgages, Insurance
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.74% |
| Yield on Cost 5y | 3.08% |
| Yield CAGR 5y | 22.64% |
| Payout Consistency | 88.7% |
| Payout Ratio | 11.5% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 36.2% |
| Value at Risk 5%th | 56.6% |
| Relative Tail Risk | -4.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.29 |
| Alpha | -23.72 |
| CAGR/Max DD | 0.54 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.373 |
| Beta | 0.601 |
| Beta Downside | 0.297 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.66% |
| Mean DD | 14.87% |
| Median DD | 9.52% |
Description: KBH KB Home November 08, 2025
KB Home (NYSE:KBH) is a U.S. homebuilder that structures its business across four geographic segments-West Coast, Southwest, Central, and Southeast-constructing and selling attached and detached single-family homes, townhomes, and condominiums. Its primary customer base includes first-time, move-up, and active-adult buyers, and the firm augments revenue with mortgage-originating, insurance, and title-service offerings.
As of its 2023 fiscal year, KB Home delivered roughly 10,200 homes, generating an average selling price of about $352 million, and reported a backlog of approximately 13,000 units-metrics that reflect both the company’s scale and exposure to housing-market cycles. The builder’s performance is tightly linked to macro drivers such as the Federal Reserve’s interest-rate policy (which directly affects mortgage rates) and regional labor-cost trends in its key markets (California, Texas, Florida). Additionally, the homebuilding sector’s inventory-to-sales ratio, currently hovering near 5 months nationally, serves as a leading indicator of demand pressure for KB Home’s price-sensitive buyer segments.
For a deeper, data-driven assessment of KB Home’s valuation dynamics, you may find ValueRay’s analytical platform worth exploring.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (428.8m TTM) > 0 and > 6% of Revenue (6% = 374.2m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 1.32pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 94.59% (prev 88.29%; Δ 6.30pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 394.5m <= Net Income 428.8m (YES >=105%, WARN >=100%) |
| Net Debt (1.46b) to EBITDA (592.4m) ratio: 2.47 <= 3.0 (WARN <= 3.5) |
| Current Ratio 17.79 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (65.0m) change vs 12m ago -13.41% (target <= -2.0% for YES) |
| Gross Margin 18.88% (prev 21.29%; Δ -2.41pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 91.60% (prev 99.91%; Δ -8.31pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| error: Interest Coverage Ratio cannot be calculated (needs EBITDA TTM and Interest Expense TTM) |
Altman Z'' 10.45
| (A) 0.88 = (Total Current Assets 6.25b - Total Current Liabilities 351.3m) / Total Assets 6.68b |
| (B) 0.53 = Retained Earnings (Balance) 3.54b / Total Assets 6.68b |
| (C) 0.08 = EBIT TTM 554.2m / Avg Total Assets 6.81b |
| (D) 2.27 = Book Value of Equity 4.64b / Total Liabilities 2.04b |
| Total Rating: 10.45 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 56.31
| 1. Piotroski 4.0pt |
| 2. FCF Yield 6.95% |
| 3. FCF Margin 5.61% |
| 4. Debt/Equity 0.37 |
| 5. Debt/Ebitda 2.47 |
| 6. ROIC - WACC (= 1.44)% |
| 7. RoE 10.32% |
| 8. Rev. Trend -1.78% |
| 9. EPS Trend -32.31% |
What is the price of KBH shares?
Over the past week, the price has changed by -0.14%, over one month by -11.53%, over three months by -9.06% and over the past year by -12.06%.
Is KBH a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 8
- Sell: 0
- Strong Sell: 2
What are the forecasts/targets for the KBH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 64.2 | 12% |
| Analysts Target Price | 64.2 | 12% |
| ValueRay Target Price | 66.4 | 15.9% |
KBH Fundamental Data Overview December 24, 2025
P/E Trailing = 9.3306
P/E Forward = 9.2593
P/S = 0.5721
P/B = 0.9298
P/EG = 0.63
Beta = 1.398
Revenue TTM = 6.24b USD
EBIT TTM = 554.2m USD
EBITDA TTM = 592.4m USD
Long Term Debt = 1.69b USD (from longTermDebt, two quarters ago)
Short Term Debt = 250.0m USD (from shortLongTermDebt, two quarters ago)
Debt = 1.69b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.46b USD (from netDebt column, last quarter)
Enterprise Value = 5.03b USD (3.57b + Debt 1.69b - CCE 228.6m)
Interest Coverage Ratio = unknown (Ebit TTM 554.2m / Interest Expense TTM 0.0)
FCF Yield = 6.95% (FCF TTM 349.8m / Enterprise Value 5.03b)
FCF Margin = 5.61% (FCF TTM 349.8m / Revenue TTM 6.24b)
Net Margin = 6.88% (Net Income TTM 428.8m / Revenue TTM 6.24b)
Gross Margin = 18.88% ((Revenue TTM 6.24b - Cost of Revenue TTM 5.06b) / Revenue TTM)
Gross Margin QoQ = 17.37% (prev 18.47%)
Tobins Q-Ratio = 0.75 (Enterprise Value 5.03b / Total Assets 6.68b)
Interest Expense / Debt = 1.57% (Interest Expense 26.6m / Debt 1.69b)
Taxrate = 21.44% (27.7m / 129.2m)
NOPAT = 435.4m (EBIT 554.2m * (1 - 21.44%))
Current Ratio = 17.79 (Total Current Assets 6.25b / Total Current Liabilities 351.3m)
Debt / Equity = 0.37 (Debt 1.69b / totalStockholderEquity, last quarter 4.64b)
Debt / EBITDA = 2.47 (Net Debt 1.46b / EBITDA 592.4m)
Debt / FCF = 4.19 (Net Debt 1.46b / FCF TTM 349.8m)
Total Stockholder Equity = 4.16b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.42% (Net Income 428.8m / Total Assets 6.68b)
RoE = 10.32% (Net Income TTM 428.8m / Total Stockholder Equity 4.16b)
RoCE = 9.47% (EBIT 554.2m / Capital Employed (Equity 4.16b + L.T.Debt 1.69b))
RoIC = 7.42% (NOPAT 435.4m / Invested Capital 5.87b)
WACC = 5.98% (E(3.57b)/V(5.26b) * Re(8.23%) + D(1.69b)/V(5.26b) * Rd(1.57%) * (1-Tc(0.21)))
Discount Rate = 8.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -10.12%
[DCF Debug] Terminal Value 69.63% ; FCFE base≈318.7m ; Y1≈209.2m ; Y5≈95.7m
Fair Price DCF = 28.83 (DCF Value 1.82b / Shares Outstanding 63.2m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -32.31 | EPS CAGR: 1.42% | SUE: -1.74 | # QB: 0
Revenue Correlation: -1.78 | Revenue CAGR: 5.25% | SUE: 0.68 | # QB: 0
EPS next Quarter (2026-02-28): EPS=0.58 | Chg30d=-0.318 | Revisions Net=-4 | Analysts=7
EPS current Year (2026-11-30): EPS=4.41 | Chg30d=-1.721 | Revisions Net=-5 | Growth EPS=-28.2% | Growth Revenue=-11.2%
EPS next Year (2027-11-30): EPS=6.31 | Chg30d=-0.955 | Revisions Net=-1 | Growth EPS=+42.9% | Growth Revenue=+6.6%
Additional Sources for KBH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle